• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TORAX MEDICAL, INC. UNK LINX MAGNETIC IMPLANT; ANTI-REFLUX IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TORAX MEDICAL, INC. UNK LINX MAGNETIC IMPLANT; ANTI-REFLUX IMPLANT Back to Search Results
Catalog Number UNK LINX MAGNETIC IMPLANT
Device Problems Device Appears to Trigger Rejection (1524); No Apparent Adverse Event (3189); Patient Device Interaction Problem (4001)
Patient Problems Dysphagia/ Odynophagia (1815); Pyrosis/Heartburn (1883); Hemorrhage/Bleeding (1888)
Event Date 10/01/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Publication year of 2020.This report is related to a journal article; therefore, no product will be returned for analysis and the manufacturing records cannot be reviewed as the lot number has not been provided.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.Kindly confirm if the presumed linx device (per note on the compliance with ethical standard) can be considered as an ethicon device for this article since no other device was mentioned?.
 
Event Description
It was reported via journal article: title: regression of barrett¿s esophagus after magnetic sphincter augmentation: intermediate-term results.Author: colin p.Dunn, justin c.Henning, jason a.Sterris, paul won, caitlin houghton, nikolai a.Bildzukewicz, john c.Lipham.Citation: doi: https://doi.Org/10.1007/s00464-020-08074-6.This is a retrospective review of 87 patients (male n=55, median bmi was 26.95) with biopsy-proven barrett¿s esophagus who underwent magnetic sphincter augmentation with linx device (ethicon) between april 2007 and september 2019.Perioperative complications of intra-operative bleeding (n=1) which required additional port placement for control (though no blood was transfused) was reported and a patient was readmitted for dysphagia (n=1) which was resolved with a course of steroids were reported.Postoperatively, patients had unchanged results of their latest biopsy (n=75%) and some patients showed who had originally short-length barret¿s had lengthening of their barrett¿s segment (n=5).Msa reduces esophageal acid exposure and can lead to reduction or resolution of barrett¿s esophagus.Msa is also effective at preventing progression of metaplasia to dysplasia or neoplasia.This effect remains consistent even after 2 years of follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK LINX MAGNETIC IMPLANT
Type of Device
ANTI-REFLUX IMPLANT
Manufacturer (Section D)
TORAX MEDICAL, INC.
4188 lexington avenue north
shoreview MN
Manufacturer Contact
kara ditty-bovard
4188 lexington avenue north
shoreview, MN 55126
6107428552
MDR Report Key11568714
MDR Text Key259465434
Report Number3008766073-2021-00050
Device Sequence Number1
Product Code LEI
Combination Product (y/n)N
PMA/PMN Number
P100049
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other
Type of Report Initial
Report Date 03/08/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/25/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK LINX MAGNETIC IMPLANT
Was Device Available for Evaluation? No
Date Manufacturer Received03/08/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-